New study highlights effectiveness of a herpesvirus CMV-based vaccine against Ebola

(University of Plymouth) As the latest in a series of studies, researchers have shown the ability of a vaccine vector based on a common herpesvirus called cytomegalovirus (CMV) expressing Ebola virus glycoprotein (GP), to provide protection against Ebola virus in the experimental rhesus macaque, non-human primate (NHP) model. Demonstration of protection in the NHP model is regarded as a critical step before translation of Ebola virus vaccines into humans and other great apes.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news